Recent Posts
- GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas Venture and Access Biotechnology
- GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer
- GRO Biosciences Presents Preclinical Data on Two ProGly™ Programs for Non-Standard Amino Acid Therapies
- GRO Biosciences CEO, Daniel J. Mandell, PhD, Awarded 2023 Termeer Fellowship
- GRO Biosciences Announces Addition of Nicole Paulk, PhD, to Scientific Advisory Board